title: Are we achieving the current waiting time targets in lung cancer treatment? Result of a prospective study from a large United kingdom teaching hospital.
abstract: BACKGROUND
  Recent United Kingdom National Cancer Plan guidelines have specified a number of waiting time targets to prevent delays in the treatment of lung cancer. This study was performed to compare our waiting times with national recommendations.
  
  
  METHODS
  All newly diagnosed cases of lung cancer presenting to our institution were entered into a prospective tracking study by a dedicated audit officer. From September 2003 to December 2005, a total of 342 patients were entered into the study. Of these, 193 (56%) were referred by general practitioners; the remaining 114 (46%) were internal referrals. The Cancer Plan waiting time targets are mainly applicable to general practitioners referrals, which formed the study group.
  
  
  RESULTS
  All the patients were seen in chest outpatient clinics within the recommended 2-week period. However, there was a delay in starting all forms of treatment. The median waiting time to any form of treatment was 60 days (recommendation, 62 days for all patients). From specialist referrals, the median waiting times for radiotherapy, surgery, and chemotherapy were 43, 25, and 16.5 days compared with recommended maximums of 28, 28, and 7 days, respectively.
  
  
  CONCLUSIONS
  These data demonstrate that although patients receive outpatient consultation in the recommended time period, the National Cancer Plan treatment target of 62 days for patients referred by general practitioners is not being achieved. A concerted effort by all clinicians is required to meet the prescribed target times.
authors.affiliation: Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester, United Kingdom. mdevbhandari@yahoo.co.uk
authors.forename: Mohan P
authors.initials: MP
authors.lastname: Devbhandari
authors.forename: Mohammad N
authors.initials: MN
authors.lastname: Bittar
authors.forename: Pauline
authors.initials: P
authors.lastname: Quennell
authors.forename: Philip
authors.initials: P
authors.lastname: Barber
authors.forename: Peotr
authors.initials: P
authors.lastname: Krysiak
authors.forename: Rajesh
authors.initials: R
authors.lastname: Shah
authors.forename: Mark T
authors.initials: MT
authors.lastname: Jones
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle; D001999:Bronchoscopy; D003131:Combined Modality Therapy / Q000592:standards; D005260:Female; D005500:Follow-Up Studies; D006784:Hospitals, Teaching; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging / Q000379:methods; D011379:Prognosis; D011446:Prospective Studies; D012017:Referral and Consultation; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon; D014057:Tomography, X-Ray Computed; D006113:United Kingdom; D014850:Waiting Lists